Introduction
The management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.
Initial Management
Inpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.
For emergency Treatment
For patients with ST-elevation myocardial Infarction (STEMI), emergent percutaneous coronary intervention (PCI) is the preferred treatment. This procedure aims to open the occluded coronary artery and promote reperfusion, ideally within a door-to-balloon time of less than 90 minutes from emergency department arrival.
When PCI is unavailable, thrombolytic agents such as alteplase, reteplase, and tenecteplase can dissolve the thrombus. This should be done with a door-to-needle time within 30 minutes of symptom onset unless contraindicated by conditions like active bleeding.
Post-Discharge Care
Discharge planning involves a comprehensive approach with the cardiac rehabilitation team, which provides:
The primary healthcare provider oversees regular follow-ups to monitor cardiovascular health, manage comorbidities, adjust medications as needed, and ensure adherence.
Dietitians offer nutritional counseling to develop a heart-healthy eating plan tailored to the patient's preferences and needs.
Conclusion
This comprehensive interprofessional approach is crucial in managing ACS, reducing complications, and promoting long-term cardiovascular health. By following these guidelines, healthcare providers can ensure the best possible outcomes for their patients.
The medical management of acute coronary syndrome aims to minimize myocardial damage, preserve myocardial function, and prevent complications.
Initial interventions include continuous cardiac monitoring in an ICU, with oxygen supplementation for patients with respiratory distress or low oxygen saturation levels.
Pharmacologically, aspirin prevents platelet aggregation, nitroglycerin dilates coronary arteries to improve blood flow, and morphine may be used to reduce pain and anxiety if nitroglycerin is ineffective.
Beta-blockers reduce myocardial oxygen demand, while ACE inhibitors help prevent myocardial remodeling.
Anticoagulants, such as low-molecular-weight heparin administered subcutaneously or unfractionated heparin administered intravenously, prevent further clot formation.
For STEMI, immediate percutaneous coronary intervention, or PCI, is performed to open the blocked artery and restore reperfusion.
Post-discharge statins are prescribed for cholesterol management.
Cardiac rehabilitation encompasses patient education, lifestyle and dietary modifications, smoking cessation, and psychosocial support.